Amniotic membrane-derived mesenchymal stromal cells for the treatment of steroid-resistant acute GVHD
Phase 1
- Conditions
- steroid resistant GVHD
- Registration Number
- JPRN-UMIN000015017
- Lead Sponsor
- Hematology Division, Internal Medicine, Hyogo college of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
Not provided
Exclusion Criteria
1 patients with Liver damage other than GVHD (Total bililubin >2.0mg/dl or AST and/or ALT>200U/L 2 patients with Serum creatinine >2mg/dl 3 patients with allergy to bovine or porcine products 4 patienst with relapsed at MSC infusion 5 patients with uncontrolled infection 6 blood O2 saturation <94% even 3L/min Oxygen supply 7 Patients attending physician has determined ineligible.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method